Your browser doesn't support javascript.
loading
Brachyury-targeted immunotherapy combined with gemcitabine against head and neck cancer.
Yamaki, Hidekiyo; Kono, Michihisa; Wakisaka, Risa; Komatsuda, Hiroki; Kumai, Takumi; Hayashi, Ryusuke; Sato, Ryosuke; Nagato, Toshihiro; Ohkuri, Takayuki; Kosaka, Akemi; Ohara, Kenzo; Kishibe, Kan; Takahara, Miki; Hayashi, Tatsuya; Kobayashi, Hiroya; Katada, Akihiro.
Afiliación
  • Yamaki H; Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Midorigaoka-Higashi 2-1-1-1, Asahikawa, 078-8510, Japan.
  • Kono M; Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Midorigaoka-Higashi 2-1-1-1, Asahikawa, 078-8510, Japan.
  • Wakisaka R; Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Midorigaoka-Higashi 2-1-1-1, Asahikawa, 078-8510, Japan.
  • Komatsuda H; Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Midorigaoka-Higashi 2-1-1-1, Asahikawa, 078-8510, Japan.
  • Kumai T; Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Midorigaoka-Higashi 2-1-1-1, Asahikawa, 078-8510, Japan. t-kumai@asahikawa-med.ac.jp.
  • Hayashi R; Department of Innovative Head and Neck Cancer Research and Treatment, Asahikawa Medical University, Asahikawa, Japan. t-kumai@asahikawa-med.ac.jp.
  • Sato R; Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Midorigaoka-Higashi 2-1-1-1, Asahikawa, 078-8510, Japan.
  • Nagato T; Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Midorigaoka-Higashi 2-1-1-1, Asahikawa, 078-8510, Japan.
  • Ohkuri T; Department of Pathology, Asahikawa Medical University, Asahikawa, Japan.
  • Kosaka A; Department of Pathology, Asahikawa Medical University, Asahikawa, Japan.
  • Ohara K; Department of Pathology, Asahikawa Medical University, Asahikawa, Japan.
  • Kishibe K; Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Midorigaoka-Higashi 2-1-1-1, Asahikawa, 078-8510, Japan.
  • Takahara M; Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Midorigaoka-Higashi 2-1-1-1, Asahikawa, 078-8510, Japan.
  • Hayashi T; Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Midorigaoka-Higashi 2-1-1-1, Asahikawa, 078-8510, Japan.
  • Kobayashi H; Department of Innovative Head and Neck Cancer Research and Treatment, Asahikawa Medical University, Asahikawa, Japan.
  • Katada A; Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Midorigaoka-Higashi 2-1-1-1, Asahikawa, 078-8510, Japan.
Cancer Immunol Immunother ; 72(8): 2799-2812, 2023 Aug.
Article en En | MEDLINE | ID: mdl-37173455
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Gemcitabina / Neoplasias de Cabeza y Cuello Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Gemcitabina / Neoplasias de Cabeza y Cuello Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Japón